Dengue Fever: Etiology, Diagnosis, Prevention and Treatment

Dengue fever (break-bone fever) is a viral disease transmitted by Aedes mosquitoes. It is caused by the Dengue virus, which is a single positive-stranded RNA virus belonging to the Flaviviridae family. Dengue fever is prevalent in tropical and subtropical areas and is a significant public health concern in many countries, including`g Nigeria. The disease is characterized by symptoms such as high fever, headache, body aches, nausea, vomiting, swollen glands, and rash. In severe cases, dengue fever can lead to complications such as bleeding, organ impairment, and dengue shock syndrome. Diagnosing dengue fever can be challenging, especially in areas where it is endemic. In endemic locations, diagnosis is often made clinically based on the patient's reported symptoms and a physical examination. Tourniquet testing, which involves applying a blood pressure cuff and counting any petechial hemorrhages, can help in the diagnosis. Laboratory methods, including full blood count, cell culture, nucleic acid identification (PCR), and serology, can be used to confirm the diagnosis. Preventing dengue fever involves controlling the mosquito vector and protecting oneself from mosquito bites. Measures such as eliminating mosquito breeding sites, using insect repellents, wearing protective clothing, and using bed nets can help prevent mosquito bites. Vaccination against dengue is also available, with the Dengvaxia vaccine being used in some countries. There is no specific antiviral treatment for dengue fever. Management focuses on supportive care, maintaining a healthy fluid balance, and relieving symptoms such as fever and pain. Severe cases may require hospitalization and intensive medical care. In Nigeria, dengue fever is often misdiagnosed or overlooked due to similarities with other febrile illnesses like malaria. This can lead to underreporting and inadequate management of dengue cases. Increasing awareness among healthcare professionals and the general population is crucial for early detection and appropriate management of dengue fever in Nigeria. In conclusion dengue fever is a viral disease transmitted by mosquitoes, primarily Aedes species. It is a significant global health concern, including in Nigeria. Early diagnosis, prevention measures, and supportive care are essential in managing dengue fever and reducing its impact on public health. This review is aimed at discussing the current issues of Dengue fever with focus on Nigeria.

[1]  D. Dwyer,et al.  Arthropod-Borne Flaviviruses in Pregnancy , 2023, Microorganisms.

[2]  B. Gessner,et al.  Updated recommendations of the International Dengue Initiative expert group for CYD-TDV vaccine implementation in Latin America. , 2019, Vaccine.

[3]  K. Uddin Dengue in 2019 , 2019, BIRDEM Medical Journal.

[4]  First FDA-approved vaccine for the prevention of dengue disease in endemic regions , 2019, Case Medical Research.

[5]  J. Walley,et al.  A cross-sectional survey on the seroprevalence of dengue fever in febrile patients attending health facilities in Cross River State, Nigeria , 2019, PloS one.

[6]  G. Nchinda,et al.  Seroprevalence of dengue virus among children with febrile illness in Nnewi, Nigeria , 2018 .

[7]  J. Mustapha,et al.  Survey of malaria and anti-dengue virus IgG among febrile HIV-infected patients attending a tertiary hospital in Abuja, Nigeria , 2017, HIV/AIDS.

[8]  J. Stanaway,et al.  The global economic burden of dengue: a systematic analysis. , 2016, The Lancet. Infectious diseases.

[9]  D. Musso,et al.  Rapid spread of emerging Zika virus in the Pacific area. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  S. Yacoub,et al.  Predicting outcome from dengue , 2014, BMC Medicine.

[11]  Dennis Normile,et al.  Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. , 2013, Science.

[12]  E. Undurraga,et al.  Economic and Disease Burden of Dengue in Southeast Asia , 2013, PLoS neglected tropical diseases.

[13]  Motayo Babatunde Olanrewaju,et al.  SEROLOGICAL EVIDENCE OF RECENT DENGUE VIRUS INFECTION AMONG FEBRILE CHILDREN IN A SEMI ARID ZONE , 2013 .

[14]  B. Guy,et al.  From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. , 2011, Vaccine.

[15]  H. Margolis,et al.  Dengue Virus Infection in Africa , 2011, Emerging infectious diseases.

[16]  Niranjan Kissoon,et al.  Dengue hemorrhagic fever and shock syndromes* , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[17]  Rosanna W. Peeling,et al.  Dengue: a continuing global threat , 2010, Nature Reviews Microbiology.

[18]  Mary E. Wilson,et al.  Dengue and chikungunya infections in travelers , 2010, Current opinion in infectious diseases.

[19]  V. Wiwanitkit Dengue fever: diagnosis and treatment , 2010, Expert review of anti-infective therapy.

[20]  A. Varatharaj Encephalitis in the clinical spectrum of dengue infection. , 2010, Neurology India.

[21]  J. Smit,et al.  Dengue virus life cycle: viral and host factors modulating infectivity , 2010, Cellular and Molecular Life Sciences.

[22]  P. Reiter,et al.  Yellow fever and dengue: a threat to Europe? , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[23]  J. Rey What is Dengue? , 2007, EDIS.

[24]  L. Wilkins Part 12: Pediatric Advanced Life Support , 2005 .

[25]  A. Kahng,et al.  International , 1964, PS: Political Science & Politics.

[26]  S. Halstead,et al.  Dengue , 1872, The Lancet.

[27]  N. Idrisa Sero-prevalence of dengue type-3 Virus among patients with febrile illnesses attending a tertiary hospital in Maiduguri , Nigeria , 2013 .

[28]  M. Talle The Effect of Climate on Dengue Virus Infections in Nigeria , 2011 .

[29]  E. Konishi [Dengue vaccine]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[30]  Healthgrid Applications and Core Technologies - Proceedings of HealthGrid 2010, University Paris XI, Orsay, Paris, France, June 28-30, 2010 , 2010, HealthGrid.

[31]  M. V. Regenmortel,et al.  Desk Encyclopedia of Human and Medical Virology , 2010 .

[32]  R. Schlesinger,et al.  Dengue Viruses , 1977, Virology Monographs Die Virusforschung in Einzeldarstellungen.